Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Patient-reported Outcomes in Bladder Cancer
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer
- Status
- UNKNOWN
- Phase
- NA
A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer:
- Status
- COMPLETED
- Phase
- N/A
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II Study of RC48-ADC in Subjects With HER2 Positive Metastatic or Unresectable Urothelial Cancer
- Status
- COMPLETED
- Phase
- PHASE2
INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neutron Radiation Therapy and Pembrolizumab in Treating Participants With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1